The purpose of this evidence synthesis protocol is to plan a series of systematic reviews on prostate cancer screening for adults aged 18 years and older to inform an update to the 2014 Task Force Recommendations on screening for prostate cancer with the prostate-specific antigen (PSA) test [1]. Here, KLK3 is linked to prostate cancer.